BNIP3L and hepatocellular carcinoma: Compared to the control group (cells transfected with empty vector), HCC-SR cells overexpressing BNIP3 or BNIP3L exhibited reduced viability (Fig. 1F) and proliferation (Fig. 1G) but an increased percentage of apoptotic cells in response to the same sorafenib treatments (Fig. 1H).